Status:
COMPLETED
Creating a Sustainable Infrastructure for SARS-CoV-2 Testing (COVID-19) at Syringe Exchange Programs
Lead Sponsor:
University of Oregon
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Health Behavior
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
PWIDs have been an underserved population in the context of the current pandemic; thus, little is known about the prevalence of COVID-19 and the acceptability and possible reach of testing for COVID-1...
Detailed Description
People who inject drugs (PWIDs) are a socially vulnerable population and are exposed to risk factors including unstable housing and underlying medical conditions such as human immunodeficiency virus (...
Eligibility Criteria
Inclusion
- Aged 18 and over
- Attend Syringe Services Program
- English speaking
Exclusion
- \-
Key Trial Info
Start Date :
April 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
205 Patients enrolled
Trial Details
Trial ID
NCT04852848
Start Date
April 14 2021
End Date
June 30 2021
Last Update
June 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Oregon
Eugene, Oregon, United States, 97403